Comprehensive curation of label-free proteomics data for 186 patient-derived xenograft (PDX) models in HuBaseTM

被引：0
|
作者：
Liu, Hengyuan
Chen, Xiaobo
Guo, Sheng
Mao, Binchen
Pal, Rekha
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-C047
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C047
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Label-free separation of neuroblastoma patient-derived xenograft (PDX) cells from hematopoietic progenitor cell products by acoustophoresis
    Olm, Franziska
    Panse, Lena
    Dykes, Josefina H.
    Bexell, Daniel
    Laurell, Thomas
    Scheding, Stefan
    STEM CELL RESEARCH & THERAPY, 2021, 12 (01)
  • [2] Label-free separation of neuroblastoma patient-derived xenograft (PDX) cells from hematopoietic progenitor cell products by acoustophoresis
    Franziska Olm
    Lena Panse
    Josefina H. Dykes
    Daniel Bexell
    Thomas Laurell
    Stefan Scheding
    Stem Cell Research & Therapy, 12
  • [3] A comprehensive predictive biomarker analysis for MEK Inhibitors in Patient-derived Xenograft (PDX) models
    Sheng, Yanghui
    Qian, Wubin
    Wang, Jingjing
    Guo, Sheng
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [4] UTILIZATION OF PATIENT-DERIVED TUMOR XENOGRAFT (PDX) MODELS IN ONCOLOGY
    Cybula, Magdalena
    Moxley, Katherine
    Wang, Lin
    Wang, Luyao
    Bieniasz, Magdalena
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 84 - 84
  • [5] Patient-derived xenograft (PDX) models, applications and challenges in cancer research
    Abdolahi, Shahrokh
    Ghazvinian, Zeinab
    Muhammadnejad, Samad
    Saleh, Mahshid
    Asadzadeh Aghdaei, Hamid
    Baghaei, Kaveh
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [6] Patient-derived xenograft (PDX) models, applications and challenges in cancer research
    Shahrokh Abdolahi
    Zeinab Ghazvinian
    Samad Muhammadnejad
    Mahshid Saleh
    Hamid Asadzadeh Aghdaei
    Kaveh Baghaei
    Journal of Translational Medicine, 20
  • [7] PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models
    Meehan, Terrence F.
    Conte, Nathalie
    Goldstein, Theodore
    Inghirami, Giorgio
    Murakami, Mark A.
    Brabetz, Sebastian
    Gu, Zhiping
    Wiser, Jeffrey A.
    Dunn, Patrick
    Begley, Dale A.
    Krupke, Debra M.
    Bertotti, Andrea
    Bruna, Alejandra
    Brush, Matthew H.
    Byrne, Annette T.
    Caldas, Carlos
    Christie, Amanda L.
    Clark, Dominic A.
    Dowst, Heidi
    Dry, Jonathan R.
    Doroshow, James H.
    Duchamp, Olivier
    Evrard, Yvonne A.
    Ferretti, Stephane
    Frese, Kristopher K.
    Goodwin, Neal C.
    Greenawalt, Danielle
    Haendel, Melissa A.
    Hermans, Els
    Houghton, Peter J.
    Jonkers, Jos
    Kemper, Kristel
    Khor, Tin O.
    Lewis, Michael T.
    Lloyd, K. C. Kent
    Mason, Jeremy
    Medico, Enzo
    Neuhauser, Steven B.
    Olson, James M.
    Peeper, Daniel S.
    Rueda, Oscar M.
    Seong, Je Kyung
    Trusolino, Livio
    Vinolo, Emilie
    Wechsler-Reya, Robert J.
    Weinstock, David M.
    Welm, Alana
    Weroha, S. John
    Amant, Frederic
    Pfister, Stefan M.
    CANCER RESEARCH, 2017, 77 (21) : E62 - E66
  • [8] Establishment and characterization of a panel of melanoma patient-derived xenograft (PDX) models.
    Gamez, Lizette
    Wick, Michael J.
    Vaught, Teresa L.
    Farley, Monica
    Tolcher, Anthony W.
    Rasco, Drew
    Patnaik, Amita
    Miller, Alex
    Drengler, Ron
    Papadopoulos, Kyriakos P.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [9] PDX Finder: An open and global catalogue of patient-derived xenograft models.
    Perova, Zinaida
    Halmagyi, Csaba
    Mosaku, Abayomi
    Conte, Nathalie
    Mason, Jeremy
    Follette, Alex
    Thorne, Ross
    Martinez, Mauricio
    Neuhauser, Steven
    Begley, Dale
    Krupke, Debra
    Parkinson, Helen
    Meehan, Terrence
    Bult, Carol
    CANCER RESEARCH, 2021, 81 (13)
  • [10] Patient-derived xenograft (PDX) models: characteristics and points to consider for the process of establishment
    Fujii, Etsuko
    Kato, Atsuhiko
    Suzuki, Masami
    JOURNAL OF TOXICOLOGIC PATHOLOGY, 2020, 33 (03) : 153 - 160
12345